Revamped OxyContin was supposed to reduce abuse, but has it? Medical Dialogues Bureau24 July 2019 9:00 AM ISTThere's just one problem: Neither the company that makes OxyContin nor the FDA has allowed the experts to see data on whether it reduces...
Cipla subsidiary gets USFDA nod for generic version of Lyrica Medical Dialogues Bureau23 July 2019 9:55 AM ISTCipla said the approved product, Pregabalin Capsules are a generic therapeutic equivalent version of Pfizer's Lyrica.New Delhi: Drug major Cipla...
GSK Pharma Q1 net profit up 35 percent at Rs 113 crore in FY20 Medical Dialogues Bureau23 July 2019 9:45 AM ISTMumbai: GlaxoSmithKline (GSK) Pharmaceuticals on Monday announced a 35 per cent jump in its net profit to Rs 113.5 crore during the first quarter of...
Laurus Labs, Rising Pharma launches neuropathic pain capsules in US Medical Dialogues Bureau23 July 2019 9:30 AM ISTRising Pharmaceuticals has launched a generic version of Lyrica capsules, in the strengths of 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg and...
Gilead licenses respiratory, herpes antiviral research programs from Novartis Medical Dialogues Bureau23 July 2019 9:15 AM ISTUnder the agreement, Gilead will acquire exclusive global rights to develop and commercialize novel small molecules against three undisclosed targets....
Bayer sells Dr Scholls footcare brand to US firm for USD 585 million Medical Dialogues Bureau23 July 2019 9:00 AM ISTBayer, whose stock has slumped amid lawsuits over an alleged cancer-causing effect of its Roundup weed killer, struck a deal in May to sell the US sun...
Different claims used by PATANJALI for marketing in India and abroad: USFDA Medical Dialogues Bureau22 July 2019 1:44 PM IST"I observed that the 'Bel Sharbat' and 'Gulab Sharbat' products are sold under the PATANJALI brand name for domestic (India) and international (USA)...
Dr Reddys closes sale of US rights for neurology products Tosymra, Zembrace Symtouch Medical Dialogues Bureau22 July 2019 12:31 PM ISTUnder the agreement, Dr Reddy's sold its US and select territory rights for Zembrace Symtouch (sumatriptan injection) 3 mg and Tosymra (sumatriptan...
Alembic Pharma gets USFDA approval for Pregabalin Capsules to manage neuropathic pain Medical Dialogues Bureau22 July 2019 10:00 AM ISTThe approved Pregabalin Capsules is therapeutically equivalent to the reference listed drug Lyrica Capsules of PF Prism CV.New Delhi: Drug firm...
USFDA completes inspection of Strides Pharma flagship unit in Bengaluru Medical Dialogues Bureau22 July 2019 9:30 AM ISTThe flagship facility of Strides Pharma in Bangalore is the largest manufacturing facility for the company with capabilities to produce finished...
Merck combo drug Recarbrio wins USFDA nod for treating cUTI, abdominal infection Medical Dialogues Bureau22 July 2019 9:15 AM ISTRecarbrio, approved for patients over 18 years of age, is a combination of a previously approved antibiotic imipenem-cilastatin and Merck & Co’s...
Zydus Cadila arm gets USFDA nod for generic version of Adderall XR capsules in US Medical Dialogues Bureau21 July 2019 10:00 AM ISTThe product is a generic version of Adderall XR capsules and will be manufactured at Nesher Pharmaceuticals' manufacturing facility at St Louis in the...
